{"name":"International Centre for Diarrhoeal Disease Research, Bangladesh","slug":"international-centre-for-diarrhoeal-disease-research-bangladesh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":24,"colorKey":"oncology","drugs":[{"name":"Quadrivalent Influenza Vaccine","genericName":"Quadrivalent Influenza Vaccine","slug":"quadrivalent-influenza-vaccine","indication":"Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in people 6 months of age and older","status":"marketed"},{"name":"Bivalent OPV 2 week interval","genericName":"Bivalent OPV 2 week interval","slug":"bivalent-opv-2-week-interval","indication":"Poliomyelitis prevention (poliovirus types 1 and 3)","status":"marketed"},{"name":"Bivalent OPV 4 week interval","genericName":"Bivalent OPV 4 week interval","slug":"bivalent-opv-4-week-interval","indication":"Other","status":"marketed"},{"name":"JE vaccine new plant lot 3","genericName":"JE vaccine new plant lot 3","slug":"je-vaccine-new-plant-lot-3","indication":"Other","status":"marketed"},{"name":"Monovalent OPV 4 week interval","genericName":"Monovalent OPV 4 week interval","slug":"monovalent-opv-4-week-interval","indication":"Other","status":"marketed"},{"name":"Rotavirus Vaccine (ROTARIX)","genericName":"Rotavirus Vaccine (ROTARIX)","slug":"rotavirus-vaccine-rotarix","indication":"Prevention of rotavirus gastroenteritis in infants and young children","status":"marketed"},{"name":"Trivalent OPV 4 week interval","genericName":"Trivalent OPV 4 week interval","slug":"trivalent-opv-4-week-interval","indication":"Poliomyelitis prevention (poliovirus types 1, 2, and 3)","status":"marketed"},{"name":"Whole cell killed cholera vaccine & probiotic","genericName":"Whole cell killed cholera vaccine & probiotic","slug":"whole-cell-killed-cholera-vaccine-probiotic","indication":"Other","status":"phase_1"},{"name":"Amylase resistant starch added ORS","genericName":"Amylase resistant starch added ORS","slug":"amylase-resistant-starch-added-ors","indication":"Acute diarrhea (cholera and non-cholera)","status":"phase_3"},{"name":"Blood and Dopamine","genericName":"Blood and Dopamine","slug":"blood-and-dopamine","indication":"Other","status":"phase_3"},{"name":"Cholvax","genericName":"Cholvax","slug":"cholvax","indication":"Other","status":"phase_2"},{"name":"Fractional IPV( fIPV)","genericName":"Fractional IPV( fIPV)","slug":"fractional-ipv-fipv","indication":"Poliomyelitis prevention in infants and children","status":"marketed"},{"name":"Hypo-osmolar ORS","genericName":"Hypo-osmolar ORS","slug":"hypo-osmolar-ors","indication":"Other","status":"marketed"},{"name":"JE Vaccine existing facility","genericName":"JE Vaccine existing facility","slug":"je-vaccine-existing-facility","indication":"Prevention of Japanese encephalitis in endemic regions","status":"marketed"},{"name":"JE vaccine new plant lot 1","genericName":"JE vaccine new plant lot 1","slug":"je-vaccine-new-plant-lot-1","indication":"Prevention of Japanese encephalitis in endemic regions","status":"marketed"},{"name":"JE vaccine new plant lot 2","genericName":"JE vaccine new plant lot 2","slug":"je-vaccine-new-plant-lot-2","indication":"Prevention of Japanese encephalitis in endemic regions","status":"marketed"},{"name":"Measles and Rubella (MR)","genericName":"Measles and Rubella (MR)","slug":"measles-and-rubella-mr","indication":"Prevention of measles","status":"phase_3"},{"name":"Mitefosine","genericName":"Mitefosine","slug":"mitefosine","indication":"Other","status":"marketed"},{"name":"Monovalent OPV 2 week interval","genericName":"Monovalent OPV 2 week interval","slug":"monovalent-opv-2-week-interval","indication":"Other","status":"marketed"},{"name":"Oral Cholera Vaccine (OCV)","genericName":"Oral Cholera Vaccine (OCV)","slug":"oral-cholera-vaccine-ocv","indication":"Prevention of cholera in individuals traveling to or living in areas where cholera is common","status":"phase_3"},{"name":"Pentavalent vaccine","genericName":"Pentavalent vaccine","slug":"pentavalent-vaccine","indication":"Other","status":"marketed"},{"name":"Rotavirus Vaccine & Breastfeeding","genericName":"Rotavirus Vaccine & Breastfeeding","slug":"rotavirus-vaccine-breastfeeding","indication":"Prevention of severe rotavirus gastroenteritis in infants and young children","status":"phase_3"},{"name":"Shanchol vaccine","genericName":"Shanchol vaccine","slug":"shanchol-vaccine","indication":"Prevention of cholera caused by Vibrio cholerae O1 and O139 in endemic and epidemic settings","status":"phase_3"},{"name":"polio vaccines: nOPV2, bOPV, IPV","genericName":"polio vaccines: nOPV2, bOPV, IPV","slug":"polio-vaccines-nopv2-bopv-ipv","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"Hepa-B","genericName":"Hepa-B","slug":"hepa-b","indication":"Prevention of hepatitis B virus infection in infants, children, and adults","status":"marketed"},{"name":"Hexavalent vaccine","genericName":"Hexavalent vaccine","slug":"hexavalent-vaccine","indication":"Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b infection in infants and children","status":"marketed"},{"name":"Pneumococcal protein vaccine","genericName":"Pneumococcal protein vaccine","slug":"pneumococcal-protein-vaccine","indication":"Prevention of pneumococcal disease (pneumonia, bacteremia, meningitis)","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Blood and adrenaline","genericName":"Blood and adrenaline","slug":"blood-and-adrenaline","indication":"Cardiogenic shock","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Oral Polio Vaccine","genericName":"Oral Polio Vaccine","slug":"oral-polio-vaccine","indication":"Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3","status":"marketed"}]}],"pipeline":[{"name":"Quadrivalent Influenza Vaccine","genericName":"Quadrivalent Influenza Vaccine","slug":"quadrivalent-influenza-vaccine","phase":"marketed","mechanism":"This vaccine works by stimulating the body's immune system to produce antibodies against influenza viruses.","indications":["Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in people 6 months of age and older","Prevention of influenza disease caused by influenza A subtype viruses (A/H1N1, A/H3N2) and influenza B viruses in people 6 months of age and older, when the circulating influenza A and B viruses are expected to be well matched to the vaccine viruses."],"catalyst":""},{"name":"Bivalent OPV 2 week interval","genericName":"Bivalent OPV 2 week interval","slug":"bivalent-opv-2-week-interval","phase":"marketed","mechanism":"Bivalent OPV provides immunization against poliovirus types 1 and 3 by stimulating the immune system to produce antibodies against these two serotypes.","indications":["Poliomyelitis prevention (poliovirus types 1 and 3)"],"catalyst":""},{"name":"Bivalent OPV 4 week interval","genericName":"Bivalent OPV 4 week interval","slug":"bivalent-opv-4-week-interval","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"JE vaccine new plant lot 3","genericName":"JE vaccine new plant lot 3","slug":"je-vaccine-new-plant-lot-3","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Monovalent OPV 4 week interval","genericName":"Monovalent OPV 4 week interval","slug":"monovalent-opv-4-week-interval","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Rotavirus Vaccine (ROTARIX)","genericName":"Rotavirus Vaccine (ROTARIX)","slug":"rotavirus-vaccine-rotarix","phase":"marketed","mechanism":"ROTARIX is a live attenuated rotavirus vaccine that stimulates the immune system to produce antibodies and cellular immunity against rotavirus infection.","indications":["Prevention of rotavirus gastroenteritis in infants and young children"],"catalyst":""},{"name":"Trivalent OPV 4 week interval","genericName":"Trivalent OPV 4 week interval","slug":"trivalent-opv-4-week-interval","phase":"marketed","mechanism":"Trivalent OPV provides immunization against three serotypes of poliovirus (types 1, 2, and 3) by inducing mucosal and systemic immune responses through oral administration of live attenuated virus.","indications":["Poliomyelitis prevention (poliovirus types 1, 2, and 3)"],"catalyst":""},{"name":"Whole cell killed cholera vaccine & probiotic","genericName":"Whole cell killed cholera vaccine & probiotic","slug":"whole-cell-killed-cholera-vaccine-probiotic","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Amylase resistant starch added ORS","genericName":"Amylase resistant starch added ORS","slug":"amylase-resistant-starch-added-ors","phase":"phase_3","mechanism":"Amylase-resistant starch in oral rehydration solution reduces stool output and improves water absorption in diarrheal disease by providing a slowly fermentable carbohydrate substrate.","indications":["Acute diarrhea (cholera and non-cholera)","Diarrheal disease in children"],"catalyst":""},{"name":"Blood and Dopamine","genericName":"Blood and Dopamine","slug":"blood-and-dopamine","phase":"phase_3","mechanism":"Unknown mechanism; the drug name suggests potential involvement in blood regulation and dopaminergic pathways, but specific molecular action is not established.","indications":[],"catalyst":""},{"name":"Blood and adrenaline","genericName":"Blood and adrenaline","slug":"blood-and-adrenaline","phase":"phase_3","mechanism":"This drug stimulates the release of adrenaline and increases blood flow to vital organs.","indications":["Cardiogenic shock"],"catalyst":""},{"name":"Cholvax","genericName":"Cholvax","slug":"cholvax","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Fractional IPV( fIPV)","genericName":"Fractional IPV( fIPV)","slug":"fractional-ipv-fipv","phase":"marketed","mechanism":"Fractional IPV (fIPV) is a reduced-dose inactivated polio vaccine that provides immunological protection against poliovirus while using a smaller antigen quantity per dose.","indications":["Poliomyelitis prevention in infants and children"],"catalyst":""},{"name":"Hepa-B","genericName":"Hepa-B","slug":"hepa-b","phase":"marketed","mechanism":"Hepa-B is a hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B virus infection.","indications":["Prevention of hepatitis B virus infection in infants, children, and adults"],"catalyst":""},{"name":"Hexavalent vaccine","genericName":"Hexavalent vaccine","slug":"hexavalent-vaccine","phase":"marketed","mechanism":"A hexavalent vaccine that provides immunization against six infectious diseases by stimulating the immune system to produce antibodies and cellular immunity against multiple pathogens.","indications":["Prevention of diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and Haemophilus influenzae type b infection in infants and children"],"catalyst":""},{"name":"Hypo-osmolar ORS","genericName":"Hypo-osmolar ORS","slug":"hypo-osmolar-ors","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"JE Vaccine existing facility","genericName":"JE Vaccine existing facility","slug":"je-vaccine-existing-facility","phase":"marketed","mechanism":"JE Vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.","indications":["Prevention of Japanese encephalitis in endemic regions"],"catalyst":""},{"name":"JE vaccine new plant lot 1","genericName":"JE vaccine new plant lot 1","slug":"je-vaccine-new-plant-lot-1","phase":"marketed","mechanism":"JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.","indications":["Prevention of Japanese encephalitis in endemic regions"],"catalyst":""},{"name":"JE vaccine new plant lot 2","genericName":"JE vaccine new plant lot 2","slug":"je-vaccine-new-plant-lot-2","phase":"marketed","mechanism":"JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.","indications":["Prevention of Japanese encephalitis in endemic regions"],"catalyst":""},{"name":"Measles and Rubella (MR)","genericName":"Measles and Rubella (MR)","slug":"measles-and-rubella-mr","phase":"phase_3","mechanism":"The MR vaccine stimulates the immune system to produce antibodies and cellular immunity against measles and rubella viruses through live attenuated viral antigens.","indications":["Prevention of measles","Prevention of rubella"],"catalyst":""},{"name":"Mitefosine","genericName":"Mitefosine","slug":"mitefosine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Monovalent OPV 2 week interval","genericName":"Monovalent OPV 2 week interval","slug":"monovalent-opv-2-week-interval","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Oral Cholera Vaccine (OCV)","genericName":"Oral Cholera Vaccine (OCV)","slug":"oral-cholera-vaccine-ocv","phase":"phase_3","mechanism":"The Oral Cholera Vaccine (OCV) works by stimulating the body's immune system to produce antibodies against Vibrio cholerae, the bacteria that causes cholera.","indications":["Prevention of cholera in individuals traveling to or living in areas where cholera is common"],"catalyst":""},{"name":"Oral Polio Vaccine","genericName":"Oral Polio Vaccine","slug":"oral-polio-vaccine","phase":"marketed","mechanism":"Oral Polio Vaccine stimulates the immune system to produce antibodies against poliovirus by delivering live attenuated (weakened) poliovirus strains orally.","indications":["Prevention of poliomyelitis caused by poliovirus types 1, 2, and 3","Routine childhood immunization against polio"],"catalyst":""},{"name":"Pentavalent vaccine","genericName":"Pentavalent vaccine","slug":"pentavalent-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Pneumococcal protein vaccine","genericName":"Pneumococcal protein vaccine","slug":"pneumococcal-protein-vaccine","phase":"marketed","mechanism":"This vaccine stimulates the immune system to produce antibodies and cellular immunity against pneumococcal protein antigens, preventing infection by Streptococcus pneumoniae.","indications":["Prevention of pneumococcal disease (pneumonia, bacteremia, meningitis)"],"catalyst":""},{"name":"Rotavirus Vaccine & Breastfeeding","genericName":"Rotavirus Vaccine & Breastfeeding","slug":"rotavirus-vaccine-breastfeeding","phase":"phase_3","mechanism":"The Rotavirus Vaccine works by stimulating the body's immune system to produce antibodies against rotavirus, thereby preventing infection.","indications":["Prevention of severe rotavirus gastroenteritis in infants and young children"],"catalyst":""},{"name":"Shanchol vaccine","genericName":"Shanchol vaccine","slug":"shanchol-vaccine","phase":"phase_3","mechanism":"Shanchol is an oral, inactivated cholera vaccine that stimulates immune responses against Vibrio cholerae O1 and O139 antigens to prevent cholera infection.","indications":["Prevention of cholera caused by Vibrio cholerae O1 and O139 in endemic and epidemic settings"],"catalyst":""},{"name":"polio vaccines: nOPV2, bOPV, IPV","genericName":"polio vaccines: nOPV2, bOPV, IPV","slug":"polio-vaccines-nopv2-bopv-ipv","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5tUUpTUXJPR1hFeE5IWVJCd3ViSXBPTUxYTFRVbXVmYjZoX0NTY2NOMWpTZjlpM2xITFFWRlJXQ1M2T2NHMVlXSDR0SUpXUUFyT3RQNi1sWTFrVGQ5TWRaX2Nya1RCbU1YczlJUTZxYlp1YjRpYWVwc3lR?oc=5","date":"2025-11-14","type":"pipeline","source":"University of Vermont","summary":"Working Locally, Solving Globally | Vermont Medicine - University of Vermont","headline":"Working Locally, Solving Globally | Vermont Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbjNoOEc4VTNvaVVWSGM0OXhmXzU2d0VGSGx1QWRzRmVLU2t6QURWNGU5OVFMRmlnZm1yU1JSRW9CZmFYeWJodDI2WTNKenRyQU1yYlo5U1ZiVjc4NlhOc0ZkNzNtQUd6ZndRcHZNcEpObUh4WjNMcEdvM0xqRDhJMGt2ZHY5VGND?oc=5","date":"2025-11-07","type":"pipeline","source":"WashU","summary":"Therapeutic food named a Best Invention of 2025 - WashU","headline":"Therapeutic food named a Best Invention of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNVFRkVzV4WjA1aVlZdEZMTUJaODAwX3U5SXN0aVg3MF94eTFzTElidXVHSVhNNHMxLUhveTktV0lOS0ZiazJnZ3RRZV84cHE1dl92MXNvTUNOOVdPSWhiblR6MFoxcEpmdGROemI2VU8zcWZOVFRJbnFseUdRbXZiQzFrQVRQRzVkdEZ1V2h5YWl0MVZVZ2YtaGVad0lfUVJ2SUFya3R4VTNCTEk1ck1zcUZST2Q?oc=5","date":"2025-10-29","type":"pipeline","source":"WashU Medicine","summary":"TIME Magazine names therapeutic microbiome-directed food a Best Invention of 2025 - WashU Medicine","headline":"TIME Magazine names therapeutic microbiome-directed food a Best Invention of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNWjlDcVdSUnc1M0NVaDNVUkk3dlM5RHA4U1pSMVpWY3RPdGlYVFhreENSc2M2akpuQ0FWZmtnZ092cC1qT2tOYXpxVVBKU3RBMXFBYmpuNzIyck1ranNoRzdFLVBfSlU0T3oxc01rSld0YVVMUEhtWWFYOHlVWnZqcER1VDJpVWRXT1pjUWpiSDk?oc=5","date":"2025-07-30","type":"pipeline","source":"Stanford Report","summary":"The hidden mental health cost of climate distress - Stanford Report","headline":"The hidden mental health cost of climate distress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBGMDJWZm9yNzd1SU9VeXRxaTRocjVQd0J4Wk1QU3h3WjVxbWhnQk9JZ1NKOERhZG5pT2pRbHRNSTRaZkdFUFZ4ZldwbTh1TDF4NktQQlozWVNZa0NEaG1BcHlmVlA5VkhxU09pa0dkRDVEZGxqMWFr?oc=5","date":"2025-07-20","type":"pipeline","source":"WashU Medicine","summary":"Childhood Malnutrition - WashU Medicine","headline":"Childhood Malnutrition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNMlZlUUQzbWRUNno3cGtMMFJyRTZQb1hSQnFodXB3Zm1xVkRyeGJuLUxJX0MwWnFNOUREUkI3ZVY2NTN6N19ReXhFNTM4VFFscEZiblNxREduYzlSWjMwM2JpNW9jZkpWdnYtdGFCQlh4UzNwSlNodnR4RmpJc3RsVWR6c0gxbVJXLTZ4SzR0NVEweG5qNzZBWExNck5KVExRcG04YjVCY0FqdGU3TVlncg?oc=5","date":"2024-11-05","type":"regulatory","source":"Stanford Report","summary":"Health experts push for the elimination of a ‘remarkably harmful toxin’ - Stanford Report","headline":"Health experts push for the elimination of a ‘remarkably harmful toxin’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPcnZaWFJCN1VtSWhhVko3VFBsRzhWWWh1MlN6c3NhcjFTT19YM2FqVzdjNHM3QTUwZUx1eW40LWlSUkFucWpJSmxkVVVjWlhwNXRqQ1RETFNtR3VrSXhmWld0OUxfQjNrVUNyOHlHWEp1TzhvcnkwU1ZlbUpYeVNmS29DcEh6YUZGVFVtNlVzSXNtSE5pSzdSSFpka1V6dFBuS1F2T3NvNnFYeE8zd0RUejVVYjdHZlBtczJxSndMN2NqQQ?oc=5","date":"2024-10-21","type":"pipeline","source":"School of Medicine | University of Utah","summary":"Daniel Leung, MD, MSc, Awarded NIH Grant for Mobile Health Tool in Bangladesh - School of Medicine | University of Utah","headline":"Daniel Leung, MD, MSc, Awarded NIH Grant for Mobile Health Tool in Bangladesh - School of Medicine | University of Utah","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOdWg2VTE4SE5YY2VnQUwyYUJrekNSLWtKeHhqMVg0S2ZPTDhJUGo5VlFJRlU4S2tNYVg0MHNLaWdpZUlod3pGN2owSWR0dUI5S3dBVVpfMUxKVnNyZlNQNzJsb2RMZHJna0E4dzZMdVN5T3I0bWt2V081MTVyUXZac0pNblY3OWYtUGVDa1lCbnBxVDFWemQ1U2g4Rm5ZUEFNNDVJTmxkdm8tdDZoQUdCU3o0clZCQjg?oc=5","date":"2024-04-19","type":"trial","source":"WashU Medicine","summary":"International trials underway for childhood malnutrition therapy developed at WashU - WashU Medicine","headline":"International trials underway for childhood malnutrition therapy developed at WashU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOcFV5MkpBVHgwWlJNNUFSZWRhUUhMdGFMdmYzaGhEV29OTGRVeURaUlRQYWpUSmlVYkFCbTQ1WlRkdU02al9Za2JqNzlSdVFEa1k2N1lMYVBsQUpJZllsYXAtZ19LX3ZqVzhwb3lNa2hhbl9BZ1JVMHdvakZPXzZMZHROOHJNMW5CRHNGMl9PSVFBNGpvdmdlbjl3ZVJTUUpH?oc=5","date":"2024-01-14","type":"pipeline","source":"American Society for Biochemistry and Molecular Biology","summary":"Gut bacteria of malnourished children benefit from key elements in therapeutic food - American Society for Biochemistry and Molecular Biology","headline":"Gut bacteria of malnourished children benefit from key elements in therapeutic food","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPY0VmZWhKYWhSc1lJSDd0eWI0cDl4YzRUenNXNGZJbklxZkdTZ1FQSU1Ma1NXNkJKSkJuU3JBaEZfNkJFNF9pR3JBSi1xOUZzMnVfWTVDYU1FZGtKTTM0UmhjVzFuaUROTmwtTFlyb1AzV19xYlUxLUNyZy1CZktVVFNhOEdMc2NQUkxqZVY0eGJTUQ?oc=5","date":"2022-06-30","type":"pipeline","source":"unr.edu","summary":"University scientists conduct, shed light on microbiome research to help impoverished children grow - unr.edu","headline":"University scientists conduct, shed light on microbiome research to help impoverished children grow","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNSXJ0eE5ZUVhZY1J1cXZOQzM1RmdNTXlhS0o4ZHhmdHY2bTNlSUFtQmZlUnBsNEpMSFJZc2cyVkRHaEVRa0FsZFRta2ctT1lfQzJ2d3hESjhPVkRtQzJuMExoLWp4b3lzcWdYNG5YdkV5YTcyckNuSnBFejM0c25vTDNJTXFkMEE1czExdm1QMjdzUDRtT1pFOHVaeWdfRi1QM3lPRkxHRXFZTEphUDdxWg?oc=5","date":"2021-04-07","type":"pipeline","source":"WashU Medicine","summary":"For malnourished children, a new type of microbiome-directed food boosts growth - WashU Medicine","headline":"For malnourished children, a new type of microbiome-directed food boosts growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOOWNieDNFZ1VoSHM5NjczUnRiVjI2cF9PTjdmSjlFbHF6cVBXNHhKVWdsWDk4M3dEZG1ZN2pfand0MWE2MXJWTUx3UkhjU0pmUy0wODM2SzktZ1I1WXBIUDN2cXZlZ28tSFVuS181ZFN5ZVloQnBzallsYXU0NWs4bkREZ0c0RnE3X1JhNS1FQnY4RjA?oc=5","date":"2019-07-11","type":"pipeline","source":"Medical Xpress","summary":"For malnourished children, new therapeutic food boosts gut microbes, healthy development - Medical Xpress","headline":"For malnourished children, new therapeutic food boosts gut microbes, healthy development","sentiment":"neutral"}],"patents":[],"drugCount":29,"phaseCounts":{"marketed":20,"phase_1":1,"phase_3":7,"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}